| 000 | 01722 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514002122.0 | ||
| 264 | 0 | _c20011204 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0263-6352 | ||
| 024 | 7 |
_a10.1097/00004872-200106000-00018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoudgil, R | |
| 245 | 0 | 0 |
_aPostischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade in isolated working rat hearts. _h[electronic resource] |
| 260 |
_bJournal of hypertension _cJun 2001 |
||
| 300 |
_a1121-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAngiotensin Receptor Antagonists |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCaspase 3 |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLosartan _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xetiology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReceptor, Angiotensin, Type 1 |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 650 | 0 | 4 | _abcl-2-Associated X Protein |
| 700 | 1 | _aMenon, V | |
| 700 | 1 | _aXu, Y | |
| 700 | 1 | _aMusat-Marcu, S | |
| 700 | 1 | _aKumar, D | |
| 700 | 1 | _aJugdutt, B I | |
| 773 | 0 |
_tJournal of hypertension _gvol. 19 _gno. 6 _gp. 1121-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004872-200106000-00018 _zAvailable from publisher's website |
| 999 |
_c11333790 _d11333790 |
||